Scientists track eye disease patterns to speed future cures

NCT ID NCT07265895

First seen Jan 07, 2026 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This study looks back at medical records of 200 people with inherited retinal diseases, like retinitis pigmentosa and Stargardt disease. Researchers will analyze vision tests and eye scans to see how these diseases progress and how genetics affect symptoms. The goal is to find better ways to measure disease changes, which could help design future treatment trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STARGARDT DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IRCCS Ospedale San Raffaele

    Milan, Italy, 20132, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help design better clinical trials and personalized care for people with inherited retinal diseases.

What could go wrong

This is an observational study, not a treatment trial. It won't directly improve vision, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

inherited retinal dystrophy retinal degeneration retinitis pigmentosa Stargardt disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.